Skip to content

Clinical trials

Phase 1 Neoplasm Metastasis trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1 Country / region: Japan Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20102
20113
20122
20132
20154
20163
20172
20182
20194
20203
20216
20224
20233
20247
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting12
Recruiting11
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company15
AstraZeneca4
Daiichi Sankyo4
Pfizer4
Astellas Pharma Inc3
AbbVie2
Boehringer Ingelheim2
EMD Serono Research & Development Institute, Inc.2
Novartis Pharmaceuticals2
Alterome Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis55
Neoplasms20
Carcinoma, Non-Small-Cell Lung17
Colorectal Neoplasms10
Squamous Cell Carcinoma of Head and Neck7
Stomach Neoplasms7
Triple Negative Breast Neoplasms7
Breast Neoplasms6
Endometrial Neoplasms6
Esophageal Neoplasms6

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.